Cim Investment Management Inc Moderna, Inc. Transaction History

Cim Investment Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$101.21 - $166.61 $172,765 - $284,403	1,707 New	1,707 $202,000
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $3,856 - $5,064	-40 Reduced 1.87%	2,104 $217,000
Q2 2023 Aug 09, 2023	BUY	$118.5 - $160.53 $592 - $802	5 Added 0.23%	2,144 $260,000
Q1 2023 May 16, 2023	BUY	$135.66 - $197.02 $11,666 - $16,943	86 Added 4.19%	2,139 $328,000
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $5,682 - $10,081	-48 Reduced 2.28%	2,053 $368,000
Q2 2022 Sep 02, 2022	SELL	$117.13 - $176.59 $1,054 - $1,589	-9 Reduced 0.43%	2,101 $300,000
Q1 2022 May 17, 2022	SELL	$126.46 - $235.05 $252 - $470	-2 Reduced 0.09%	2,110 $363,000
Q4 2021 May 19, 2022	SELL	$225.82 - $368.51 $268,048 - $437,421	-1,187 Reduced 35.98%	2,112 $536,000
Q4 2021 Feb 02, 2022	BUY	$225.82 - $368.51 $476,931 - $778,293	2,112 Added 177.93%	3,299 $993,000
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $263,395 - $575,065	1,187 New	1,187 $457,000

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $17.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cim Investment Management Inc with notifications on news.